Forward Pharma (FWP) Reports Q4 Loss of $1.01/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Leerink Partners Sees Forward Pharma (FWP) Shares Inflecting on Upcoming Patent Interference Decision
March 26, 2015 7:57 AM EDTLeerink Partners analyst Jason Gerberry reiterated an Outperform rating and $40 price target on Forward Pharma (NASDAQ: FWP), saying the shares to inflect on upcoming patent interference decision.
Gerberry commented, "We caught up with Joel Sendek, FWP's CFO, post this morning's financial results. Key updates... More



